In the subset of patients who did not receive systemic treatment initially, i.e., those observed or treated only with local radiation, the presence of prevalent nonsynonymous BCL2 mutations was also associated with earlier time to lymphoma-associated death (Fig. 3A). Here, BCL2 is linked to lymphoma.